Evidence map›Paper›PMID 36292198›Full record

ArticleDiagnostics (Basel, Switzerland)2022

Model Building in Forensic Psychiatry: A Machine Learning Approach to Screening Offender Patients with SSD.

Lena Machetanz, David Huber, Steffen Lau, Johannes Kirchebner

Abstract read
In one paragraph

Article in Diagnostics (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Lena MachetanzDepartment of Forensic Psychiatry, Psychiatric Hospital, University of Zürich, 3002 Zurich, Switzerland.ORCID 0000-0001-6838-9380
David HuberDepartment of Forensic Psychiatry, Psychiatric Hospital, University of Zürich, 3002 Zurich, Switzerland.
Steffen LauDepartment of Forensic Psychiatry, Psychiatric Hospital, University of Zürich, 3002 Zurich, Switzerland.ORCID 0000-0002-3175-3457
Johannes KirchebnerDepartment of Forensic Psychiatry, Psychiatric Hospital, University of Zürich, 3002 Zurich, Switzerland.ORCID 0000-0002-6072-9958

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Today's extensive availability of medical data enables the development of predictive models, but this requires suitable statistical methods, such as machine learning (ML). Especially in forensic psychiatry, a complex and cost-intensive field with risk assessments and predictions of treatment outcomes as central tasks, there is a need for such predictive tools, for example, to anticipate complex treatment courses and to be able to offer appropriate therapy on an individualized basis. This study aimed to develop a first basic model for the anticipation of adverse treatment courses based on prior compulsory admission and/or conviction as simple and easily objectifiable parameters in offender patients with a schizophrenia spectrum disorder (SSD). With a balanced accuracy of 67% and an AUC of 0.72, gradient boosting proved to be the optimal ML algorithm. Antisocial behavior, physical violence against staff, rule breaking, hyperactivity, delusions of grandeur, fewer feelings of guilt, the need for compulsory isolation, cannabis abuse/dependence, a higher dose of antipsychotics (measured by the olanzapine half-life) and an unfavorable legal prognosis emerged as the ten most influential variables out of a dataset with 209 parameters. Our findings could demonstrate an example of the use of ML in the development of an easy-to-use predictive model based on few objectifiable factors.

Indexed as

adverse treatment courseartificial intelligenceforensic psychiatrymachine learningmodel buildingschizophrenia

Identifiers

PMID36292198
PMCPMC9600890

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.